Tyrosine and tryptophan hydroxylation are the rate limiting steps for production of dopamine, norepinephrine and serotonin.1 There is good evidence that the availability of tetrahydrobiopterin (BH4), the pterin cofactor for these reactions, is important in controliling the rate of this hydroxylation.2 3 This pterin is present in high concentrations in monoaminergic pathways, where it is probably synthesised intraneuronally. 4 It is also present in other organs of the body and in serum but does not readily cross the blood-brain barrier.3 CSF hydroxylase cofactor content, predominantly consisting of BH4, therefore, may reflect levels -in brain, probably with a large contribution from the aminergic neurons of the basal ganglia.
In a previous study5 it was demonstrated that: (1) hydroxylase cofactor, which is predominantly composed of BH4, can be measured reliably in lumbar CSF; (2) Patients with Parkinson's disease, the ShyDrager syndrome, the Steele-Richardson syndrome, essential tremor, Huntington's disease and presenile dementia all had abnormally low values compared with their age matched controls (p<O0O1 by unpaired 't' test). The patients with focal dystonia had normal levels.
Discussion
The critical role for BH4 for the synthesis of 
